Shlomo Melmed, MD

The research focus of Dr. Shlomo Melmed is molecular pathogenesis of pituitary tumors and pituitary receptor signaling..

He employs molecular, cellular, transgenic animal and human tissue models to understand the biology of these commonly encountered hormone-secreting adenomas. He tests pituitary receptor signaling to develop novel peptide analog treatments for these tumors secreting growth hormone, prolactin, ACTH or gonadotropins.

  • Executive Vice President, Academic Affairs
  • Dean of the Medical Faculty
  • Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine
  • Professor, Medicine